Collegium Pharmaceutical (COLL) Gross Profit (2016 - 2025)
Historic Gross Profit for Collegium Pharmaceutical (COLL) over the last 10 years, with Q3 2025 value amounting to $129.2 million.
- Collegium Pharmaceutical's Gross Profit rose 3344.94% to $129.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $433.2 million, marking a year-over-year increase of 1591.74%. This contributed to the annual value of $377.3 million for FY2024, which is 1568.97% up from last year.
- As of Q3 2025, Collegium Pharmaceutical's Gross Profit stood at $129.2 million, which was up 3344.94% from $108.4 million recorded in Q2 2025.
- Collegium Pharmaceutical's 5-year Gross Profit high stood at $129.2 million for Q3 2025, and its period low was -$1.3 million during Q4 2021.
- Over the past 5 years, Collegium Pharmaceutical's median Gross Profit value was $77.4 million (recorded in 2023), while the average stood at $73.6 million.
- As far as peak fluctuations go, Collegium Pharmaceutical's Gross Profit plummeted by 10300.96% in 2021, and later surged by 383510.88% in 2022.
- Over the past 5 years, Collegium Pharmaceutical's Gross Profit (Quarter) stood at -$1.3 million in 2021, then skyrocketed by 3835.11% to $49.8 million in 2022, then skyrocketed by 90.06% to $94.6 million in 2023, then grew by 3.87% to $98.3 million in 2024, then surged by 31.42% to $129.2 million in 2025.
- Its Gross Profit stands at $129.2 million for Q3 2025, versus $108.4 million for Q2 2025 and $97.3 million for Q1 2025.